FDA Leadership Changes Reflect Budgetary, Scientific Challenges
This article was originally published in RPM Report
Executive Summary
FDA has a new chief operating officer and medical officer. The appointments reflect the challenges of a lean budget and calls for a chief scientist from the Institute of Medicine.